Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells
about
hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicineGenome Engineering with TALE and CRISPR Systems in NeuroscienceInduced Pluripotent Stem Cells as a Novel Tool in Psychiatric ResearchModeling ALS and FTD with iPSC-derived neuronsSynthetic biology and therapeutic strategies for the degenerating brain: Synthetic biology approaches can transform classical cell and gene therapies, to provide new cures for neurodegenerative diseasesAge-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD.Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease PhenotypesThe unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristicsRNA stores tau reversibly in complex coacervatesTargeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones.Investigating human disease using stem cell models.Genomic editing tools to model human diseases with isogenic pluripotent stem cells.Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells.Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.Advances in reprogramming-based study of neurologic disordersProbing disorders of the nervous system using reprogramming approaches.Using Human iPSC-Derived Neurons to Model TAU Aggregation.Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPTAmyloid in dementia associated with familial FTLD: not an innocent bystander.Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice.The Tau/A152T mutation, a risk factor for frontotemporal-spectrum disorders, leads to NR2B receptor-mediated excitotoxicity.Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases.MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations.Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neuronsAdvancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein.Human stem cell models of neurodegeneration: a novel approach to study mechanisms of disease development.Human stem cell models of dementia.Neural crest cells: from developmental biology to clinical interventions.Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia.Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.Concise Review: Heteroplasmic Mitochondrial DNA Mutations and Mitochondrial Diseases: Toward iPSC-Based Disease Modeling, Drug Discovery, and Regenerative Therapeutics.Gene correction in patient-specific iPSCs for therapy development and disease modeling.Review: Induced pluripotent stem cell models of frontotemporal dementia.ALS/FTLD: experimental models and reality.May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells.Modeling tau pathology in human stem cell derived neurons.Human iPSC-Derived Neuronal Model of Tau-A152T Frontotemporal Dementia Reveals Tau-Mediated Mechanisms of Neuronal Vulnerability.The ER under rapid fire.Translational synthetic biology.
P2860
Q26751506-ABF55AF3-0442-4005-8852-632F82FF37A9Q26752488-D3B8BA18-865F-4D81-BF4C-8A95FAFA3FB7Q26772019-78BDD3EA-9262-4EBA-A2A0-3C95AF8C91D6Q26783672-9AE7618C-82B7-4078-BD1D-3793A4AE9988Q26830610-C166B72F-8D60-4A33-A81E-7E9953E3D3D2Q27317039-F4572A1F-B57F-41E8-B1B2-E1D28C661D5DQ27324311-2E954887-8FE7-4385-9383-44F2116E7CB8Q33778423-3665ED54-8E39-4C58-9C0B-9B2FC6EC2E66Q33879490-6D01B948-7FE6-4CCB-9F54-BD7D8221F188Q34088395-A110293F-10DD-4C05-A111-0AE216BE9DE8Q34431170-49F55E3F-5F9E-43A6-8319-8ED54AA8E73BQ34437293-38D345EF-8214-4A39-938D-83474416F938Q34845881-C5C8840B-650A-4C79-AAF1-22EED7B24D91Q35037783-6FABEE99-CF61-4A05-A2D4-2AA92CD4D59FQ35635245-29D6FCB1-2B41-4324-93D8-FBA52AD54243Q35761135-85819775-A708-4590-AADF-A89820F74137Q35882729-06F00988-20CF-4428-A1C6-A34648EE36F5Q35999257-7B8BD041-6573-48F5-998D-0FAFA108D364Q36327682-3178282B-F6E8-4F53-BAA9-C2E76CD35505Q36759553-9CB05D61-FF9E-401F-88E9-BE21B05618E2Q36759557-2CE36D29-537D-47A5-84ED-38A1573F0799Q36904682-2F2AE166-772E-43B7-8EE5-32FAC87425D7Q37274907-C0BA21CF-B2AF-403D-B02A-ED751051A0F7Q37324286-1D61DA97-D60C-405F-AE42-8D91620FCEADQ37624658-D7CB11CF-62D0-4A6A-A1AE-6D4D0C417D7CQ37678874-17C2BC6C-17B4-458A-9906-A2073D961A9EQ38168763-8A633C01-9A31-4404-A22B-01D9A5AC04A2Q38221121-9D658775-3EA3-4B63-AF03-50A5498E9A94Q38250145-B8B9C5F1-2871-4F32-8076-9DE37EE1139DQ38542017-9CC1DABD-53DE-4FEF-A576-4B4390FCF6DFQ38666481-6012BACD-72C1-485C-8856-E4B79908D499Q38724510-F7EB5195-E422-404B-B899-72B3EE449633Q38852141-35F44E5A-A972-4968-898F-8A2F31006AF0Q38862587-A703235A-5C05-49D7-984C-75D7125B3BEAQ39069506-7902A0B8-0ADB-4421-A096-CDBB95581E94Q39126523-795EDDA7-60F6-4FDA-8756-A74F5D842733Q39353869-8F9F64C2-708C-4677-8FBA-F44875A5CC75Q41151197-52059283-8AF6-4F91-9D94-61B157324485Q42129406-991EA4BF-9D8A-4000-973B-44A189977BF4Q42365674-890632B3-3800-4C15-94D0-B52CA2949FC5
P2860
Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic correction of tauopath ...... induced pluripotent stem cells
@en
Genetic correction of tauopath ...... nduced pluripotent stem cells.
@nl
type
label
Genetic correction of tauopath ...... induced pluripotent stem cells
@en
Genetic correction of tauopath ...... nduced pluripotent stem cells.
@nl
prefLabel
Genetic correction of tauopath ...... induced pluripotent stem cells
@en
Genetic correction of tauopath ...... nduced pluripotent stem cells.
@nl
P2093
P2860
P50
P1433
P1476
Genetic correction of tauopath ...... induced pluripotent stem cells
@en
P2093
Anna Karydas
Chengzhong Wang
David Walker
Helen Fong
Johanna Knoferle
Karen L Ring
Kenneth S Kosik
Laura Leung
Leslie M Tong
Maureen E Balestra
P2860
P304
P356
10.1016/J.STEMCR.2013.08.001
P577
2013-08-29T00:00:00Z